LakeShore Biopharma Co Ltd (LSB)
0.60
+0.02
(+2.56%)
USD |
NASDAQ |
Jun 21, 16:00
0.6059
+0.01
(+0.98%)
After-Hours: 20:00
LakeShore Biopharma Shareholders Equity (Quarterly): 76.35M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 76.35M |
June 30, 2023 | 91.09M |
Date | Value |
---|---|
September 30, 2022 | -133.41M |
March 31, 2022 | -109.94M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-133.41M
Minimum
Sep 2022
91.09M
Maximum
Jun 2023
-18.98M
Average
-16.79M
Median
Shareholders Equity (Quarterly) Benchmarks
Sinovac Biotech Ltd | 8.709B |
CASI Pharmaceuticals Inc | 15.47M |
Zai Lab Ltd | 762.17M |
China SXT Pharmaceuticals Inc | 5.076M |
Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 220.84M |
Total Liabilities (Quarterly) | 144.48M |
Debt to Equity Ratio | 0.9778 |
Current Ratio | 1.409 |
Net Debt Paydown Yield | -10.09% |